The 2026 European Drug Report shows drug markets are transforming, with cocaine accessibility increasing and synthetic drug production rising across Europe.
[This is an automatically generated summary, for reference only]
The 2026 European Drug Report indicates that Europe’s drug market is transforming rather than collapsing under law enforcement pressure. While seized cocaine tonnage decreased from 419 to 330 tons, the number of seizures increased, suggesting smaller, more dispersed shipments and evolving smuggling methods. Major ports still see large-scale sea imports, but networks are increasingly using smaller ports, fast boats, submarines, and drones. Spain remains a key entry point for cocaine due to its proximity to Latin America, routes from Morocco for cannabis, and significant domestic cultivation. Cocaine is a major public health concern, with rising residue levels in urban wastewater and increased demand for treatment, affecting over a quarter of drug-related deaths across twenty countries, increasingly among vulnerable populations like the homeless. Furthermore, Europe is becoming a production area for synthetic drugs, with numerous laboratories identified for substances like amphetamines and MDMA. Regarding cannabis, the report highlights various regulated trials in countries such as Germany, Malta, and the Netherlands, alongside new health risks from high-potency extracts and North American imports. When questioned about harm reduction efforts, EUDA acknowledged areas needing improvement but maintained that Europe is making progress compared to other regions.
